Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


15.05.2017

1 Acta Neuropathol
1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Ann Pharmacother
3 Brain
5 Curr Alzheimer Res
3 J Alzheimers Dis
1 J Am Geriatr Soc
2 J Neurosci
1 N Engl J Med
4 Neurobiol Aging
1 Neurol Genet
1 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. JIN WS, Shen LL, Bu XL, Zhang WW, et al
    Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Acta Neuropathol. 2017 May 5. doi: 10.1007/s00401-017-1721.
    PubMed     Text format     Abstract available


    Alzheimer Dis Assoc Disord

  2. MICHAUD TL, High R, Charlton ME, Murman DL, et al
    Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 May 8. doi: 10.1097/WAD.0000000000000198.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  3. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Text format     Abstract available


    Ann Pharmacother

  4. HYTTINEN V, Taipale H, Tolppanen AM, Tanskanen A, et al
    Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease.
    Ann Pharmacother. 2017 May 1:1060028017708394. doi: 10.1177/1060028017708394.
    PubMed     Text format     Abstract available


    Brain

  5. SCHWARZ AJ, Yu P, Miller BB, Shcherbinin S, et al
    Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Brain. 2016.
    PubMed     Text format     Abstract available

  6. ALVES S, Churlaud G, Klatzmann D, Cartier N, et al
    Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
    Brain. 2017 May 12. doi: 10.1093.
    PubMed     Text format    

  7. DANSOKHO C, Aucouturier P, Dorothee G
    Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
    Brain. 2017 May 12. doi: 10.1093.
    PubMed     Text format    


    Curr Alzheimer Res

  8. ZARROUK A, Debbabi M, Bezine M, Karym EM, et al
    Lipid Biomarkers in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505101426.
    PubMed     Text format     Abstract available

  9. MARCELLI S, Corbo M, Iannuzzi F, Negri L, et al
    The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095109.
    PubMed     Text format     Abstract available

  10. ARMAND-UGON M, Ansoleaga B, Berjaoui S, Ferrer I, et al
    Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer's disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095921.
    PubMed     Text format     Abstract available

  11. D ORIO B, Fracassi A, Ceru MP, Moreno S, et al
    Targeting Pparalpha In Alzheimer`s Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505094549.
    PubMed     Text format     Abstract available

  12. AHMAD J, Akhter S, Rizwanullah M, Khan MA, et al
    Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.
    Curr Alzheimer Res. 2017 May 8. doi: 10.2174/1567205014666170508121031.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  13. YOSHINO Y, Yamazaki K, Ozaki Y, Sao T, et al
    INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-161211.
    PubMed     Text format     Abstract available

  14. PASQUINI L, Benson G, Grothe MJ, Utz L, et al
    Individual Correspondence of Amyloid-beta and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170096.
    PubMed     Text format     Abstract available

  15. NELSON TJ, Sun MK, Lim C, Sen A, et al
    Bryostatin Effects on Cognitive Function and PKCvarepsilon in Alzheimer's Disease Phase IIa and Expanded Access Trials.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170161.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  16. CALLAHAN CM
    Alzheimer's Disease: Individuals, Dyads, Communities, and Costs.
    J Am Geriatr Soc. 2017 May 5. doi: 10.1111/jgs.14808.
    PubMed     Text format     Abstract available


    J Neurosci

  17. SELLES MC, Fortuna JTS, Santos LE
    Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?
    J Neurosci. 2017;37:4864-4867.
    PubMed     Text format    

  18. ROYEA J, Zhang L, Tong XK, Hamel E, et al
    Angiotensin IV receptors mediate the cognitive and cerebrovascular benefits of losartan in a mouse model of Alzheimer's disease.
    J Neurosci. 2017 May 5. pii: 0329-17. doi: 10.1523/JNEUROSCI.0329-17.2017.
    PubMed     Text format     Abstract available


    N Engl J Med

  19. SACKS CA, Avorn J, Kesselheim AS
    The Failure of Solanezumab - How the FDA Saved Taxpayers Billions.
    N Engl J Med. 2017;376:1706-1708.
    PubMed     Text format    


    Neurobiol Aging

  20. PORTER G, Wattam-Bell J, Bayer A, Haworth J, et al
    Different trajectories of decline for global form and global motion processing in aging, mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging. 2017;56:17-24.
    PubMed     Text format     Abstract available

  21. LOPEZ-SANCHEZ N, Fontan-Lozano A, Palle A, Gonzalez-Alvarez V, et al
    Neuronal tetraploidization in the cerebral cortex correlates with reduced cognition in mice and precedes and recapitulates Alzheimer's-associated neuropathology.
    Neurobiol Aging. 2017;56:50-66.
    PubMed     Text format     Abstract available

  22. BOS I, Vos SJ, Frolich L, Kornhuber J, et al
    The frequency and influence of dementia risk factors in prodromal Alzheimer's disease.
    Neurobiol Aging. 2017;56:33-40.
    PubMed     Text format     Abstract available

  23. SCHINDLER SE, Jasielec MS, Weng H, Hassenstab JJ, et al
    Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease.
    Neurobiol Aging. 2017;56:25-32.
    PubMed     Text format     Abstract available


    Neurol Genet

  24. N'SONGO A, Carrasquillo MM, Wang X, Burgess JD, et al
    African American exome sequencing identifies potential risk variants at Alzheimer disease loci.
    Neurol Genet. 2017;3:e141.
    PubMed     Text format     Abstract available


    Neurology

  25. KIKUCHI A, Okamura N, Hasegawa T, Harada R, et al
    In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Neurology. 2016 Oct 28. pii: 10.1212/WNL.0000000000003375.
    PubMed     Text format     Abstract available


    PLoS One

  26. TASCONE LDS, Payne ME, MacFall J, Azevedo D, et al
    Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease.
    PLoS One. 2017;12:e0177169.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  27. LI Q, Navakkode S, Rothkegel M, Soong TW, et al
    Metaplasticity mechanisms restore plasticity and associativity in an animal model of Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2017 May 8. pii: 201613700.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: